Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing ...

A study by the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) reveals that inflammation ...

BOSTON, May 13, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients ...

Keros Therapeutics, Inc. ("Keros" or the "Company") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing ...

Keros' cash and cash equivalents as of March 31, 2025 was $720.5 million compared to $559.9 million as of December 31, 2024.

The membranes were then probed with primary antibodies: rabbit anti-human AQP3 (dilution 1:10; catalog no. YLA1093HU; Shanghai YL Biotech Co., Ltd.), rabbit anti-human TGF-β1 (dilution 1:30; catalog ...

Apple has officially rolled out iOS 18.5 Beta 4 for developers, marking a significant milestone in the journey toward the final public release. This update emphasizes performance improvements ...

Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced multiple ...

This month, Apple began testing the next iteration of watchOS 11 – watchOS 11.5. The company has already released the three beta builds and today rolled out the fourth beta as an incremental upgrade.

Economists polled by Reuters April 16-24 trimmed their forecasts by a median 0.2 percentage point to 1.5% for this year. Forecasts were in a 1.0%-2.1% range compared with 1.3%-2.3% in a March poll.